Interactions between migraine and stroke

Current Treatment Options in Neurology

Volumn 8, Issue 6, 2006, Pages 513-517

  Weinberger, Jesse ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DISOPYRAMIDE; DIURETIC AGENT; FLECAINIDE; LAMOTRIGINE; LITHIUM; MAGNESIUM SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PAPAVERINE; PHENYTOIN; PROPRANOLOL; QUINIDINE; THEOPHYLLINE; TISSUE PLASMINOGEN ACTIVATOR; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ARTERIOVENOUS MALFORMATION; ARTICLE; BRADYCARDIA; BRAIN HEMORRHAGE; CAROTID ARTERY INJURY; CHEMOPROPHYLAXIS; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DEHYDRATION; DISTAL PARESTHESIA; DIZZINESS; DRUG BLOOD LEVEL; DRUG POTENTIATION; ENDOVASCULAR SURGERY; FAMILIAL HEMIPLEGIC MIGRAINE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOCALCEMIA; HYPOTENSION; KIDNEY FAILURE; METABOLIC ACIDOSIS; MIGRAINE; MIGRAINE WITH AURA; MYOPIA; NEUROLOGIC DISEASE; RASH; RECURRENT DISEASE; RISK FACTOR; SOMNOLENCE; STROKE; TETANY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 33750605901     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0041-7     Document Type: Article

References (31)

1. Teive HAG, Kowacs PA, Maranhao F, et al.: Leao's cortical spreading depression. From experimental "artifact" to physiological principle. Neurology 2005, 65:1455-1459.
2. Waeber C, Moskowitz MA: Migraine as an inflammatory disorder. Neurology 2005, 64:S9-S15.
3. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA: Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005, 128:2068-2077.
4. Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427-434.
5. Welch KMA: Relationship of stroke and migraine. Neurology 1994, 44(Suppl 7):S33-S36.
6. Bousser MG, Welch MA: Relation between migraine and stroke. Lancet Neurol 2005, 4:533-542.
7. Rothrock JF, Walicke P, Swenson MR, et al.: Migrainous stroke. Arch Neurol 1988, 45:63-67.
8. Rothrock J, North J, Madden K, et al.: Migraine and migrainous stroke: risk factors and prognosis. Neurology 1993, 43:2473-2476.
9. Diener HC, Weimar C, Katsarava Z: Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005, 18:299-304.
10. Schwerzmann M, Nedeltchev K, Lagger F, et al.: Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005, 65:1415-1418.
11. Anzola GP, Morandi E, Casilli F, Onorato E: Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 2006, 66:765-767.
12. Durcros A, Diener HC, Joutel A, et al.: The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001, 345:17-24.
13. Thomsen LL, Eriksen MK, Romer SF, et al.: An epidemiological survey of hemiplegic migraine. Cephalalgia 2002, 22:361-375.
14. Chabriat H, Joutel K, Vahedi E, et al.: CADASIL. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. In Stroke: Pathophysiology, Diagnosis and Management. Edited by Mohr JP, Choi DW, Grotta JC, et al. Philadelphia: Churchill Livingstone; 2004:687-692.
15. Hirano M, Pavlakis SG: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): current concepts. J Child Neurol 1994, 9:4-13.
16. Yu W, Horowitz S: Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology 2001, 57:1732-1733.
17. Yu W, Horowitz SH: Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003, 60:120-121.
18. Vijayan N: Brief therapeutic report: papaverine prophylaxis of complicated migraine. Headache 1977, 17:159-162.
19. Bigal ME, Bordini Ca, Tepper SJ, Speciali JG: Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002, 22:345-353.
20. D'Amico D, Grazzi L, Usai S, et al.: Toprimate in migraine prophylaxis. Neurol Sci 2005, 26:S130-S133.
21. Lampi C, Bonelli S, Ransmayr G: Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients. Headache 2004, 44:174-177.
22. D'Andrea GD, Allais G, Grazzi L, Fumagalli L: Migraine with aura from pathophysiology to treatment: therapeutic strategies. Neurol Sci 2005, 26:S104-S107.
23. Fuller GN, Fuiloff RJ: Propranolol in acute migraine: a controlled study. Cephalalgia 1990, 10:229-233.
24. Limmroth V, Michel MC: The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 2001, 52:237-243.
25. Baumel B: Migraine: a pharmacologic review with newer options and delivery modalities. Neurology 1994, 44:S13-S17.
26. Hall GC, Brown MM, Mo J, MacRae K: Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563-568.
27. Combrement PC, Marcus E: Intracranial hemorrhages associated with sumatriptan. Neurology 2001, 56:1243-1244.
28. Scott PA, Silbergleit R: Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 2003, 42:611-619.
29. Homma S, Sacco RL: Patent foramen ovale and stroke. Circulation 2005, 112:1063-1072.
30. Reisman M, Christofferson RD, Jesurum J, et al.: Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005, 45:493-495.
31. Giardini A, Donti GA, Formigari A, et al.: Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006, 151:922.e1-922.e5.